Skip to main content

NL
FR
EN

Other information and services: www.belgium.be Logo of the Belgian Federal Authorities

Your medicine and health products

About the FAMHP
Jobs
Publications
Press
Contact
Complaints
Webportal

Search

Home
Human use
Veterinary use
Information for the public
Information for professionals
Fees based on the turnover made in Belgium and payments

Home
Human use
Medicines
Current Page:Medicines

Medicines

COVID-19
- Research and development
- Vaccines
Scientific-technical advice
- Introduction
- Procedures
- Regulation
- Fees
- FAQ's
- Statistics
National Innovation Office
Research & Development
Marketing Authorisation procedures
Pharmacovigilance
Production
Distribution & Delivery
Autorisations - certificates
Declarations - Registrations
Proper use of medicine

Last updated on 16/12/2020

Notification of adverse reactions or incidents

PIL and SPC
of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)

News

28/07/2021

Give your opinion on a genetically modified medicine to treat dementia

26/07/2021

Unavailability of Visudyne 15 mg (powder for solution for infusion) : recommendations for (hospital) pharmacists and physicians-specialists

16/07/2021

Discontinuation of the telephone contact point of the Marketing Authorisation Division (variations and renewals)

16/07/2021

First information session on the new Clinical Trial Regulation (CTR) on 23 September 2021

© 2016 - FAMHP

202110
202110
Disclaimer

instructions how to enable JavaScript in your web browser